SI2989205T1 - Bakterijski umetni kromosomi - Google Patents

Bakterijski umetni kromosomi

Info

Publication number
SI2989205T1
SI2989205T1 SI201431153T SI201431153T SI2989205T1 SI 2989205 T1 SI2989205 T1 SI 2989205T1 SI 201431153 T SI201431153 T SI 201431153T SI 201431153 T SI201431153 T SI 201431153T SI 2989205 T1 SI2989205 T1 SI 2989205T1
Authority
SI
Slovenia
Prior art keywords
artificial chromosomes
bacterial artificial
bacterial
chromosomes
artificial
Prior art date
Application number
SI201431153T
Other languages
English (en)
Inventor
Kai Dallmeier
Johan Neyts
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Publication of SI2989205T1 publication Critical patent/SI2989205T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • C12N15/69Increasing the copy number of the vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI201431153T 2013-04-26 2014-04-25 Bakterijski umetni kromosomi SI2989205T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1307528.8A GB201307528D0 (en) 2013-04-26 2013-04-26 Bacterial artificial chromosomes
EP14724009.7A EP2989205B1 (en) 2013-04-26 2014-04-25 Bacterial artificial chromosomes
PCT/EP2014/058459 WO2014174078A1 (en) 2013-04-26 2014-04-25 Bacterial artificial chromosomes

Publications (1)

Publication Number Publication Date
SI2989205T1 true SI2989205T1 (sl) 2019-05-31

Family

ID=48626864

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201431153T SI2989205T1 (sl) 2013-04-26 2014-04-25 Bakterijski umetni kromosomi

Country Status (17)

Country Link
US (2) US10076564B2 (sl)
EP (2) EP3540065A1 (sl)
JP (1) JP6501756B2 (sl)
KR (1) KR102170609B1 (sl)
CN (1) CN105229153A (sl)
AU (1) AU2014259354B2 (sl)
BR (1) BR112015026531B1 (sl)
DK (1) DK2989205T3 (sl)
ES (1) ES2718187T3 (sl)
GB (1) GB201307528D0 (sl)
HU (1) HUE042886T2 (sl)
PL (1) PL2989205T3 (sl)
PT (1) PT2989205T (sl)
SI (1) SI2989205T1 (sl)
TR (1) TR201904215T4 (sl)
WO (1) WO2014174078A1 (sl)
ZA (1) ZA201507795B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201716307D0 (en) 2017-10-05 2017-11-22 Univ Leuven Kath Chimeric yellow fever zika virus strain
GB201716254D0 (en) * 2017-10-05 2017-11-22 Univ Leuven Kath Live-attenuated flaviruses with heterologous antigens
WO2019204654A1 (en) * 2018-04-18 2019-10-24 Utah State University Compositions and methods for zika virus characterization and vaccine development
GB201814563D0 (en) 2018-09-07 2018-10-24 Univ Leuven Kath Chimeric flavivirus lyssavirus vaccines
CN114072168A (zh) 2019-04-10 2022-02-18 勒芬天主教大学 嵌合寨卡-日本脑炎病毒
US20220378903A1 (en) 2019-09-13 2022-12-01 Katholieke Universiteit Leuven Lassavirus vaccines
US20220402976A1 (en) 2019-09-13 2022-12-22 Katholieke Universiteit Leuven Chimeric filovirus vaccines
CN114450408A (zh) 2019-09-25 2022-05-06 鲁汶天主教大学 大载体和用于高产量生产的方法
WO2021170869A1 (en) 2020-02-27 2021-09-02 Katholieke Universiteit Leuven Coronavirus vaccines

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665600A (en) 1991-09-18 1997-09-09 Research Corporation Technologies, Inc. Pichia pastoris linear plasmids and DNA fragments thereof
US5866404A (en) 1995-12-06 1999-02-02 Yale University Yeast-bacteria shuttle vector
US6962708B1 (en) 1997-02-28 2005-11-08 Acambis, Inc. Chimeric flavivirus vaccines
US5874259A (en) * 1997-11-21 1999-02-23 Wisconsin Alumni Research Foundation Conditionally amplifiable BAC vector
US6573090B1 (en) 1998-12-09 2003-06-03 The General Hospital Corporation Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
ES2170622B1 (es) 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
GB2372991B (en) * 2001-03-09 2004-11-17 Fiocruz Fundacao Oswaldo Cruz Flavivirus expression vector
US6472177B1 (en) 2001-04-23 2002-10-29 Wisconsin Alumni Research Foundation Expression vector with dual control of replication and transcription
US6864087B2 (en) 2001-07-31 2005-03-08 Wisconsin Alumni Research Foundation Method for converting single-copy BAC vectors to conditional high-copy pBAC/oriHC vectors
JPWO2003056023A1 (ja) 2001-12-25 2005-05-12 株式会社イーベック 大腸菌人工染色体として増殖可能な二本鎖環状dna
WO2004033633A2 (en) 2002-10-04 2004-04-22 Embiosis Pharmaceuticals Compatible host/vector systems for expression of dna
US20070036827A1 (en) 2003-10-29 2007-02-15 The University Of Queensland West nile virus vaccine
US20050214838A1 (en) 2004-03-10 2005-09-29 Waclaw Szybalski Methods for mapping and sequencing nucleic acids
WO2009053988A1 (en) 2007-10-25 2009-04-30 Ramot At Tel-Aviv University Ltd. Production of bac vectors carrying viral genomes
CN101864442A (zh) * 2010-05-19 2010-10-20 江苏省农业科学院 重组火鸡疱疹病毒细菌人工染色体转移载体

Also Published As

Publication number Publication date
BR112015026531A2 (sl) 2017-09-05
AU2014259354B2 (en) 2020-02-27
CN105229153A (zh) 2016-01-06
BR112015026531B1 (pt) 2023-02-07
TR201904215T4 (tr) 2019-04-22
US10076564B2 (en) 2018-09-18
EP2989205A1 (en) 2016-03-02
DK2989205T3 (en) 2019-04-23
US20160206723A1 (en) 2016-07-21
KR20160003032A (ko) 2016-01-08
WO2014174078A1 (en) 2014-10-30
ES2718187T3 (es) 2019-06-28
AU2014259354A1 (en) 2015-11-05
JP2016518132A (ja) 2016-06-23
PT2989205T (pt) 2019-04-23
HUE042886T2 (hu) 2019-07-29
JP6501756B2 (ja) 2019-04-17
US20190111125A1 (en) 2019-04-18
EP3540065A1 (en) 2019-09-18
GB201307528D0 (en) 2013-06-12
KR102170609B1 (ko) 2020-10-28
PL2989205T3 (pl) 2019-06-28
EP2989205B1 (en) 2019-01-02
ZA201507795B (en) 2019-07-31

Similar Documents

Publication Publication Date Title
IL266651B (en) graft
EP3010564B8 (en) Artificial ventricles
AU356418S (en) Charger
EP3571926C0 (en) HAPLOID EMBRYOGENESIS
ZA201507795B (en) Bacterial artificial chromosomes
IL240970B (en) Live faces
EP3168920A4 (en) Nickel-zinc battery
EP3076477A4 (en) Nickel-zinc battery
EP3037112A4 (en) PROSTHESIS
EP3168922A4 (en) Nickel-zinc battery
EP3030071A4 (en) GROWING SYSTEM
EP3533412C0 (en) ENHANCED DISINTEGRABLE BONE IMPLANTS
SG11201602576TA (en) Hearing aid
PL2970845T3 (pl) Bioreaktor
GB201310918D0 (en) Prosthesis
EP3168921A4 (en) Nickel-zinc battery
GB201307275D0 (en) Drivetrain Connections
EP2970545A4 (en) GRAY POLYETHYLENE
EP2970860A4 (en) GENETICALLY MODIFIED BACTERIA
PL2826522T3 (pl) Rozrusznik serca
DK3049043T3 (en) Indirekte tryk- og temperaturmåling i et totalt væskeventilationssystem
IL230230A0 (en) graft
GB201310756D0 (en) Implant
GB201406825D0 (en) Plug-in battery
TWM475759U (en) Charger